BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 20078388)

  • 1. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
    Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
    Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
    J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolating cytomegalovirus-specific T cells for adoptive transfer: are we there yet?
    Bollard CM
    Cytotherapy; 2010 Nov; 12(7):857-8. PubMed ID: 20942604
    [No Abstract]   [Full Text] [Related]  

  • 6. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
    J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L; Sun Q; Lucas KG
    J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
    Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
    J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.
    Nguyen TH; Sullivan LC; Kotsimbos TC; Schwarer AP; Mifsud NA
    Immunol Cell Biol; 2010 Aug; 88(6):676-84. PubMed ID: 20195281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
    J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines.
    Meij P; Jedema I; Zandvliet ML; van der Heiden PL; van de Meent M; van Egmond HM; van Liempt E; Hoogstraten C; Kruithof S; Veld S; Marijt EW; von dem Borne PA; Lankester AC; Halkes CJ; Falkenburg JH
    J Immunother; 2012 Oct; 35(8):621-8. PubMed ID: 22996368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
    Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects.
    Slezak SL; Bettinotti M; Selleri S; Adams S; Marincola FM; Stroncek DF
    J Transl Med; 2007 Mar; 5():17. PubMed ID: 17391521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.
    Trivedi D; Williams RY; O'Reilly RJ; Koehne G
    Blood; 2005 Apr; 105(7):2793-801. PubMed ID: 15514011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy.
    Zandvliet ML; Falkenburg JH; Jedema I; Willemze R; Guchelaar HJ; Meij P
    J Immunother; 2009 Jun; 32(5):513-23. PubMed ID: 19609244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals.
    Kern F; Bunde T; Faulhaber N; Kiecker F; Khatamzas E; Rudawski IM; Pruss A; Gratama JW; Volkmer-Engert R; Ewert R; Reinke P; Volk HD; Picker LJ
    J Infect Dis; 2002 Jun; 185(12):1709-16. PubMed ID: 12085315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.
    Flinsenberg TW; Spel L; Jansen M; Koning D; de Haar C; Plantinga M; Scholman R; van Loenen MM; Nierkens S; Boon L; van Baarle D; Heemskerk MH; Boelens JJ; Boes M
    J Virol; 2015 Jan; 89(2):1058-69. PubMed ID: 25378489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.